Friedreich's Ataxia Pipeline Highlights - 2018

  • ID: 4516469
  • Report
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The latest report Friedreich's Ataxia Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Friedreich's Ataxia market. It covers emerging therapies for Friedreich's Ataxia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Friedreich's Ataxia pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Friedreich's Ataxia pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Friedreich's Ataxia pipeline products by the company.

Short-term Launch Highlights:
Find out which Friedreich's Ataxia pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:
  • Friedreich's Ataxia phase 3 clinical trial pipeline products
  • Friedreich's Ataxia phase 2 clinical trial pipeline products
  • Friedreich's Ataxia phase 1 clinical trial pipeline products
  • Friedreich's Ataxia preclinical research pipeline products
  • Friedreich's Ataxia discovery stage pipeline products
  • Friedreich's Ataxia pipeline products short-term launch highlights
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Friedreich's Ataxia Pipeline by Stages
2. Friedreich's Ataxia Pipeline by Drug Class
3. Friedreich's Ataxia Pipeline by Company
4. Friedreich's Ataxia Phase 3 Clinical Trial Insights
5. Friedreich's Ataxia Phase 2 Clinical Trial Insights
6. Friedreich's Ataxia Phase 1 Clinical Trial Insights
7. Friedreich's Ataxia Preclinical Research Insights
8. Friedreich's Ataxia Discovery Stage Insights
9. Appendix
10. Research Methodology

List of Tables
Table 1: Friedreich's Ataxia Phase 3 Clinical Trials, 2018
Table 2: Friedreich's Ataxia Phase 2 Clinical Trials, 2018
Table 3: Friedreich's Ataxia Phase 1 Clinical Trials, 2018
Table 4: Friedreich's Ataxia Preclinical Research, 2018
Table 5: Friedreich's Ataxia Discovery Stage, 2018

List of Figures
Figures 1: Friedreich's Ataxia Pipeline Molecules by Clinical Trials Stage, 2018
Figure 2: Friedreich's Ataxia Pipeline Molecules by Drug Class, 2018
Figure 3: Friedreich's Ataxia Pipeline Molecules by Company, 2018
Figure 4: Friedreich's Ataxia Phase 3 Clinical Trial Highlights, 2018
Figure 5: Friedreich's Ataxia Phase 2 Clinical Trial Highlights, 2018
Figure 6: Friedreich's Ataxia Phase 1 Clinical Trial Highlights, 2018
Figure 7: Friedreich's Ataxia Preclinical Research Highlights, 2018
Figure 8: Friedreich's Ataxia Discovery Stage Highlights, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll